Literature DB >> 16814372

Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice.

Maureen P Howell1, Louis J Muglia.   

Abstract

Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is associated with vulnerability to a number of psychiatric diseases including major depression, bipolar disorder, anxiety disorders, and schizophrenia. The HPA axis is activated in response to stress and in a characteristic circadian rhythm, resulting in the release of glucocorticoid hormones from the adrenal cortex. These hormones act on peripheral target tissues to restore homeostasis to the organism and engage glucocorticoid receptors (GR) in the CNS to control the intensity and duration of the stress response. Alterations in this glucocorticoid sensing system may underlie the HPA axis changes associated with psychiatric disorders. Recently, a number of lines of mice with genetically altered GR signaling in the CNS have been generated to address this hypothesis. Here, we summarize findings from new genetic models that indicate a critical role for GR signaling in the CNS in normal regulation of the HPA axis and behavioral/emotional stability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814372     DOI: 10.1016/j.yfrne.2006.05.001

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  18 in total

1.  Administration of human leptin differentially affects parameters of cortisol secretion in socially housed female rhesus monkeys.

Authors:  Lynn A Collura; Jackie B Hoffman; Mark E Wilson
Journal:  Endocrine       Date:  2009-10-24       Impact factor: 3.633

Review 2.  Are BDNF and glucocorticoid activities calibrated?

Authors:  F Jeanneteau; M V Chao
Journal:  Neuroscience       Date:  2012-09-26       Impact factor: 3.590

3.  Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet.

Authors:  Z Michailidou; R N Carter; E Marshall; H G Sutherland; D G Brownstein; E Owen; K Cockett; V Kelly; L Ramage; E A S Al-Dujaili; M Ross; I Maraki; K Newton; M C Holmes; J R Seckl; N M Morton; C J Kenyon; K E Chapman
Journal:  FASEB J       Date:  2008-08-12       Impact factor: 5.191

4.  Central amygdala glucocorticoid receptor action promotes fear-associated CRH activation and conditioning.

Authors:  Benedict J Kolber; Marie S Roberts; Maureen P Howell; David F Wozniak; Mark S Sands; Louis J Muglia
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

Review 5.  The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.

Authors:  M R Bruchas; B B Land; C Chavkin
Journal:  Brain Res       Date:  2009-08-28       Impact factor: 3.252

6.  Characterization of a novel gain of function glucocorticoid receptor knock-in mouse.

Authors:  Junhui Zhang; Renshang Ge; Catherine Matte-Martone; Julie Goodwin; Warren D Shlomchik; Mark J Mamula; Ali Kooshkabadi; Matthew P Hardy; David Geller
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

7.  Genetic deletion of Lsamp causes exaggerated behavioral activation in novel environments.

Authors:  Elizabeth Haldeman Catania; Aurea Pimenta; Pat Levitt
Journal:  Behav Brain Res       Date:  2007-12-07       Impact factor: 3.332

8.  Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study.

Authors:  Elaine F Walker; Hanan D Trotman; Brad D Pearce; Jean Addington; Kristin S Cadenhead; Barbara A Cornblatt; Robert Heinssen; Daniel H Mathalon; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Tyrone D Cannon; Thomas H McGlashan; Scott W Woods
Journal:  Biol Psychiatry       Date:  2013-04-03       Impact factor: 13.382

9.  The clinical implications of mouse models of enhanced anxiety.

Authors:  Simone B Sartori; Rainer Landgraf; Nicolas Singewald
Journal:  Future Neurol       Date:  2011-07-01

10.  Effects of repeated treatment with cholecystokinin sulfated octapeptide on passive avoidance memory under chronic restraint stress in male rats.

Authors:  Malihe Sadeghi; Maryam Radahmadi; Parham Reisi
Journal:  Adv Biomed Res       Date:  2015-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.